In findings with potentially important implications for cervical cancer screening, scientists at Montefiore Einstein Comprehensive Cancer Center have developed a test for detecting a type of cervical cancer that Pap tests often miss. The findings were published online in the Journal of the National Cancer Institute (JNCI).
“Our novel test appears sensitive for detecting cervical adenocarcinoma [ADC]—which now accounts for up to 25% of cervical cancer cases—as well as its precursor lesions, adenocarcinoma in situ [AIS], that often develop into ADCs,” said Howard Strickler, MD, MPH, Leader, Cancer Epidemiology Prevention & Control Program, Montefiore Einstein Comprehensive Cancer Center, Harold and Muriel Block Chair in Epidemiology & Population Health, Division Head and Professor, Epidemiology & Population Health, Albert Einstein College of Medicine, and co-senior and corresponding author of the JNCI paper, “Because ADCs are often missed by current screening methods, they have higher mortality rates than the more common cervical squamous cell cancer,” Dr. Strickler added. “Our goal is to catch the disease early, before it develops into cancer.”